These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. Coccaro EF Am J Psychiatry; 2012 Jun; 169(6):577-88. PubMed ID: 22535310 [TBL] [Abstract][Full Text] [Related]
25. History of childhood maltreatment in intermittent explosive disorder and suicidal behavior. Fanning JR; Meyerhoff JJ; Lee R; Coccaro EF J Psychiatr Res; 2014 Sep; 56():10-7. PubMed ID: 24935900 [TBL] [Abstract][Full Text] [Related]
26. Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. Rosell DR; Slifstein M; Thompson J; Xu X; Perez-Rodriguez MM; McClure MM; Hazlett EA; New AS; Nabulsi N; Huang Y; Carson RE; Siever LS; Abi-Dargham A; Koenigsberg HW Psychopharmacology (Berl); 2023 Feb; 240(2):361-371. PubMed ID: 36640190 [TBL] [Abstract][Full Text] [Related]
27. Comorbid intermittent explosive disorder and posttraumatic stress disorder: Clinical correlates and relationship to suicidal behavior. Fanning JR; Lee R; Coccaro EF Compr Psychiatry; 2016 Oct; 70():125-33. PubMed ID: 27624432 [TBL] [Abstract][Full Text] [Related]
28. Subtypes of aggression in intermittent explosive disorder. Fanning JR; Coleman M; Lee R; Coccaro EF J Psychiatr Res; 2019 Feb; 109():164-172. PubMed ID: 30551023 [TBL] [Abstract][Full Text] [Related]
29. Male axillary extracts modify the affinity of the platelet serotonin transporter and impulsiveness in women. Marazziti D; Masala I; Baroni S; Polini M; Massimetti G; Giannaccini G; Betti L; Italiani P; Fabbrini L; Caglieresi C; Moschini C; Canale D; Lucacchini A; Mauri M Physiol Behav; 2010 Jun; 100(4):364-8. PubMed ID: 20347855 [TBL] [Abstract][Full Text] [Related]
30. Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects. Lee R; Chong B; Coccaro E Psychopharmacology (Berl); 2011 May; 215(1):41-8. PubMed ID: 21181128 [TBL] [Abstract][Full Text] [Related]
31. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356 [TBL] [Abstract][Full Text] [Related]
33. Norepinephrine function in personality disorder: plasma free MHPG correlates inversely with life history of aggression. Coccaro EF; Lee R; McCloskey M CNS Spectr; 2003 Oct; 8(10):731-6. PubMed ID: 14712171 [TBL] [Abstract][Full Text] [Related]
34. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age. Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949 [TBL] [Abstract][Full Text] [Related]
36. Assessment of subjective sleep quality and issues in aggression: Intermittent Explosive Disorder compared with psychiatric and healthy controls. Hall OT; Coccaro EF Compr Psychiatry; 2022 Jan; 112():152270. PubMed ID: 34702562 [TBL] [Abstract][Full Text] [Related]